← Back to Search

Surgical Device

Staples Versus Suture for Cesarean Wound Closure (SVS Trial)

N/A
Waitlist Available
Led By Dana Figueroa, MD
Research Sponsored by University of Alabama at Birmingham
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
* cesarean delivery
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at end of follow-up, 4 - 6 weeks post partum
Awards & highlights
No Placebo-Only Group

Summary

The objective of this randomized controlled trial is to compare wound morbidity (including disruption and infection) in surgical staples versus absorbable subcuticular suture for wound closure in cesarean deliveries.

Eligible Conditions
  • Wound

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4-6 weeks post partum
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4-6 weeks post partum for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Percent of Subjects With Composite Wound Morbidity.
Secondary study objectives
Composite Cosmesis Score (Stony Brook Scar Evaluation Score - SBSES) Core - SBSES))
Operative Procedure Time.
Post Operative Pain - 4 - 6 Weeks Post Delivery
+4 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Active Control
Group I: Surgical staplesActive Control1 Intervention
Patients in this arm will receive surgical staples for wound closure.
Group II: Absorbable Subcuticular Surgical SutureActive Control1 Intervention
Patients in this arm will receive absorbable subcuticular suture for wound closure of cesarean deliveries.

Find a Location

Who is running the clinical trial?

University of Alabama at BirminghamLead Sponsor
1,656 Previous Clinical Trials
2,443,977 Total Patients Enrolled
Dana Figueroa, MDPrincipal InvestigatorUniversity of Alabama at Birmingham
~24 spots leftby Jan 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top